Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1 2

Status

Completed 5

Sponsor Class

OTHER 8INDUSTRY 5

Study Type

Interventional 5

Sponsor

Cancer Type

Thoracic 15Head & Neck 7Gastrointestinal 5Tumor-Agnostic 4Genitourinary 3Endocrine 3Breast 3Plasma cell 1Other solid neoplasm 1Gynecologic 1

Conditions

Colorectal Neoplasms 2Rectal Neoplasms 1Pancreatic Neoplasms 1Neoplasms 1Gallbladder Neoplasms 1Colonic Neoplasms 1Cholangiocarcinoma 1Carcinoma, Hepatocellular 1Biliary Tract Neoplasms 1

Interventions

Gemcitabine 302Fluorouracil 296Oxaliplatin 269Bevacizumab 267Capecitabine 233Leucovorin 229pembrolizumab 215Irinotecan 185Cisplatin 142Cetuximab 142Nivolumab 131Paclitaxel 117130-nm albumin-bound paclitaxel 117Sorafenib 86Albumin-Bound Paclitaxel 75Docetaxel 65regorafenib 64atezolizumab 64IFL protocol 61Folfox protocol 61Trastuzumab 55Panitumumab 47durvalumab 46Ramucirumab 43Injections 43Sunitinib 41Drug Therapy 41Carboplatin 40trifluridine tipiracil drug combination 38lenvatinib 38

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
INDUSTRY × vandetanib × Gastrointestinal × Clear all
NCT00508001 2016-10-10

Phase II Study of Best Support Care (BSC) Plus ZD6474(Vandetanib) in Patients With Inoperable Hepatocellular Carcinoma (HCC)

Sanofi

Phase 2 Completed
67 enrolled 12 charts
Gastrointestinal

Carcinoma, Hepatocellular, Neoplasms

NCT00753675 2016-10-10

VANGOGH

Sanofi

Phase 2 Completed
174 enrolled 12 charts
Gastrointestinal

Biliary Tract Neoplasms, Gallbladder Neoplasms, Cholangiocarcinoma

NCT00454116 2016-10-07

A Phase II, Double Blind Study of 2 Doses of ZACTIMAâ„¢(ZD6474) in Combination With FOLFIRI vs FOLFIRI Alone for the Treatment of Colorectal Cancer in Patients

Sanofi

Phase 2 Completed
106 enrolled 8 charts
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT00681798 2016-08-29

Dose Escalation Study With Zactima and Chemotherapy in Metastatic Pancreas Carcinoma

Sanofi

Phase 1 Completed
8 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT00496509 2016-08-26

Phase I Efficacy On Vascular Permeability In Patients With Advanced Colorectal Cancer

Sanofi

Phase 1 Completed
24 enrolled
Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡